
|
Report Date : |
3rd
June 2006 |
IDENTIFICATION
DETAILS
|
Name : |
KLIMERS CO LTD |
|
|
|
|
Registered Office : |
2266-22 Shimoshidanmi-Anagahori Moriyamaku Nagoya
463-0003 Japan |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31/03/2006 |
|
|
|
|
Date of Incorporation : |
Sept 1997 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Engaged
in the business of mail-order medical checkup services |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
Maximum Credit Limit : |
YEN 1 MILLION |
|
|
|
|
Status : |
Poor |
|
|
|
|
Payment Behaviour : |
Regular
|
|
|
|
|
Litigation : |
Clear |
KLIMERS
CO LTD
Klimers
KK
2266-22
Shimoshidanmi-Anagahori Moriyamaku Nagoya 463-0003 JAPAN
Tel:
052-736-6821
Fax:
052-736-6827
E-Mail address: info@klimers.com
Mail-order medical checkup services
Tokyo
At the caption address, Kobe (--Clinical laboratories)
TOKUTARO TOKUDA, PRES
In million Yen, unless otherwise stated
FINANCES WEAK A/SALES Yen
125 M
PAYMENTS REGULAR CAPITAL Yen
419 M
TREND SLOW WORTH Yen 150 M*
STARTED 1997 EMPLOYES 13
*..
Negative net worth.
MAIL ORDER MEDICAL CHECKUP SERVICES. FINANCIAL SITUATION CONSIDERED WEAK BUT SHOULD BE GOOD FOR
MODERATE BUSINESS ENGAGEMENTS.
MAX
CREDIT LIMIT: YEN 1 MILLION, FULLY SECURED TERMS RECOMMENDED.
The subject company was established by Masaki Kobayashi as KK
Enkaku Iryo Kenkyusho in order to provide computer-analysis of biochemical and
pharmaceuticals catering to pharmaceutical mfrs and laboratories. Also wholesale of clinical reagents and
other drugs. In Apr 2005, the firm
restructured to recover from red ink operations, by reducing operations to
focus on providing mail-order medical checkup services as a mainline. At the same time, M Kobayashi stepped down
from the presidency to be succeeded by T Tokuda. The firm has major business firms as shareholders, such as golf
course operators, chain store operators, medical associations, other.
The sales volume for Mar/2005 fiscal term amounted to Yen 125
million, a 49% down from Yen 245 million in the previous term. This is referred to the reduced operations
to switching to mail-order medical checkups.
The operations continued in the red for three successive years to register
Yen 25 million net losses for the term.
Note the negative net worth at Yen 150 million.
For the term ended Mar 2006 the operations are thought to have
come back to profitability but profits still limited to a minimum amount post-taxes,
on an 8% rise in turnover, to Yen 135 million.
The financial situation is considered WEAK but should be good for
MODERATE business engagements. Max
credit limit is estimated at Yen 1 million, on fully secured terms recommended. The firm is funded by major business firms
but its financial strength appears still fairly WEAK. A credit line at the above amount is recommended under
guarantee.
Date Registered: Sept
1997
Legal Status: Limited Company (Kabushiki Kaisha)
Authorized: 30,000 shares
Issued: 8,385 shares
Sum: Yen 419 million
Major shareholders (%): Sumisho Bio-Science, Fuji Baking, Fuji
Country Club, Aeon, Japan Asia Investment Fund, Masaki Kobayashi (Detailed breakdown
unavailable)
No. of shareholders: 7
Nothing detrimental is known as to the commercial morality of executives.
Activities: Provider of mail order medical checkups for individuals and business firms (--100%).
Clients: [Medical laboratories, medical assoc, business firms] Handa City Medical Assoc, Fuji Bakery, Fuji Country Club, other.
No. of accounts: 500
Domestic areas of activities: Nationwide
Suppliers: [Medical assoc, laboratories] Isekyu Co, Cahc Co, other.
Payment record: Regular
Location: Business area in Nagoya. Office premises at the caption address are leased and maintained satisfactorily.
Seto Shinkin Bank (Nagoya)
Juroku Bank (Nagoya)
Relations: Satisfactory
(In Million Yen)
|
Terms Ending: |
|
31/03/2006 |
31/03/2005 |
245 |
|
|
Annual Sales |
|
135 |
125 |
245 |
|
|
Recur. Profit |
|
.. |
.. |
.. |
|
|
Net Profit |
|
0 |
-25 |
-160 |
|
|
Total Assets |
|
|
N/A |
N/A |
|
|
Net Worth |
|
|
150 |
175 |
|
|
Capital, Paid-Up |
|
|
419 |
419 |
|
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
|
|
<Analytical Data> |
(%) |
(%) |
(%) |
||
|
S.Growth Rate |
8.00 |
-48.98 |
16.67 |
||
|
Current Ratio |
|
|
.. |
.. |
|
|
N.Worth Ratio |
|
.. |
.. |
||
|
N.Profit/Sales |
0.00 |
-20.00 |
-65.31 |
||
Notes: Financials are only partially disclosed.
Forecast (or estimated) figures for the 31/03/2006 fiscal term.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |